HomeStocksMIRM

MIRM — structural market context

Mirum Pharmaceuticals, Inc. Co

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

MIRM short interest & days to cover

SHARES SHORT
6.8M
% OF FLOAT
DAYS TO COVER
12.1
CHANGE VS PRIOR
-6.2%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-07-31 (20d ago)

MIRM fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-07-31 · 20d72$112.59
2026-07-28 · 23d226K$114.2
2026-07-27 · 24d228K$113.03

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

MIRM insider buying and selling (Form 4)

Last 12 months, open-market only: 0 purchases · 1 sale

InsiderTypeSharesValueFiled
Howe Jolanda · officer: SVP, GLOBAL CONTROLLERSell (S)40K$4.0M2026-08-19

SEC Form 4 filings, open-market purchases and sales only (codes P and S); grants and option exercises excluded. Attributed public records.

Frequently asked questions

Are insiders buying MIRM?
In the last 12 months of SEC Form 4 filings, MIRM recorded 0 open-market insider purchases and 1 open-market sale (codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
Is this page telling me to buy or sell MIRM?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerAnalyst Accuracy trackerThe platform

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.